Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 50Leukemia 15Gastrointestinal Stromal Tumors 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Chronic-Phase 8Neoplasms 5Philadelphia Chromosome 4Myeloproliferative Disorders 4Leukemia, Myeloid 4Bone Marrow Diseases 4Blast Crisis 4Hematologic Diseases 3Hematologic Neoplasms 2Bronchiolitis Obliterans Syndrome 2Recurrence 1Piebaldism 1Neoplastic Processes 1Neoplasms by Histologic Type 1Melanoma 1Mastocytosis, Systemic 1Leukemia, Myeloid, Accelerated Phase 1Hypereosinophilic Syndrome 1Disease Progression 1

Interventions

Cyclosporine 3Methotrexate 2Imatinib Mesylate 2Dasatinib 2Cyclophosphamide 2ponatinib 1olverembatinib 1nilotinib 1fludarabine phosphate 1Whole-Body Irradiation 1Transplantation 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1MK-8776 1Homoharringtonine 1Fentanyl 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Myeloid, Accelerated Phase × nilotinib × Clear all
NCT00413270 2011-07-13

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Novartis

No longer available
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡